Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tonabersat multiple-dose food-effect study in healthy volunteers
NL-OMON35227Phase 1Active, not recruiting
- Sponsor
- Upsher-Smith Laboratories
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tonabersat in migraine (5 arms), sponsored by Upsher-Smith Laboratories. Primary endpoints: Safety, Tolerability and 2 more. Started Oct 2011; status: active, not recruiting.
02
Drugs
tonabersat
03
Conditions
migraine
Beyond the preview
Go deeper on NL-OMON35227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35227.